Utah Medical Products, Inc.
UTMD
$63.12
$0.250.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.57M | 2.63M | 3.05M | 3.04M | 2.90M |
| Total Depreciation and Amortization | 760.00K | 769.00K | 758.00K | 721.00K | 730.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.00K | 215.00K | -63.00K | -136.00K | 133.00K |
| Change in Net Operating Assets | 86.00K | 263.00K | -870.00K | 838.00K | -828.00K |
| Cash from Operations | 3.48M | 3.88M | 2.87M | 4.46M | 2.94M |
| Capital Expenditure | -109.00K | -27.00K | -51.00K | -184.00K | -9.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -109.00K | -27.00K | -51.00K | -184.00K | -9.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -994.00K | -653.00K | -3.49M | -3.22M | -6.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -977.00K | -988.00K | -1.00M | -1.02M | -1.04M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.97M | -1.64M | -4.49M | -4.24M | -7.75M |
| Foreign Exchange rate Adjustments | 92.00K | -122.00K | 520.00K | 307.00K | -657.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.49M | 2.09M | -1.15M | 349.00K | -5.48M |